Procter & Gamble Health (PGHL.NS) Osake Kurssi
Procter & Gamble Health Kurssi
Liikevaihto on kasvanut 7,9 % vuodessa viimeisten 19 vuoden aikana 14,08 Mrd. INR:een. Osakekohtainen tulos on kasvanut 4,8 % vuodessa viimeisten 19 vuoden aikana. Procter & Gamble Healthn nettomarginaali on nyt 23,2 %, noussut 17,3 %:sta muutama vuosi sitten. Procter & Gamble Healthn osinkotuotto on tällä hetkellä noin 2,42 %. Jakosuhde on noin 63 % tuloksesta. Osinko on kasvanut 10,7 % vuodessa viimeisten 18 vuoden aikana. Analyytikoiden mediaanitavoitehinta on 5 339,70 INR, eli yli nykyhintaa 3,5 %. 7 analyytikosta 6 suosittaa ostoa — kokonaiskonsensus on Osta.
Procter & Gamble Health osakekurssi
Procter & Gamble Health liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Procter & Gamble Health -osakkeesta
The business model of Procter & Gamble Health Ltd revolves around manufacturing and selling a wide range of consumer healthcare products. As a subsidiary of Procter & Gamble Company, it focuses on developing and marketing products that help consumers improve their health and well-being. Procter & Gamble Health Ltd aims to offer innovative pharmaceuticals, over-the-counter medications, and personal care products to meet the needs of its customers. By consistently delivering high-quality and reliable products, the company strives to maintain a strong market presence and generate sustainable revenue growth.
Procter & Gamble Health Ltd is primarily active in the healthcare industry.
The main competitors of Procter & Gamble Health Ltd in the market are Johnson & Johnson, Pfizer Inc., GlaxoSmithKline plc, and Sanofi.
Procter & Gamble Health Ltd, previously known as Merck Limited, is a leading healthcare company in India. The company has a rich history that dates back to 1967 when it was incorporated as a joint venture between Merck & Co. Inc. (USA) and a local promoter group. Over the years, it has established itself as a trusted name in the pharmaceutical industry, providing a wide range of innovative healthcare solutions. Procter & Gamble Health Ltd focuses on delivering high-quality products in areas such as vitamins, cough drops, and over-the-counter medicines. With its commitment to improving the well-being of consumers, the company continues to play a vital role in shaping the healthcare landscape in India.
Procter & Gamble Health Ltd has achieved various significant milestones throughout its history. With a rich legacy spanning decades, the company has successfully established itself as a leader in the healthcare industry. It has consistently delivered innovative and high-quality healthcare solutions, contributing to improved well-being and quality of life for consumers worldwide. Procter & Gamble Health Ltd has continually expanded its product portfolio, ranging from over-the-counter medications and nutritional supplements to personal care products. Additionally, the company has achieved noteworthy financial growth, expanding its market reach and generating substantial value for its shareholders. Procter & Gamble Health Ltd's commitment to excellence and continuous innovation has solidified its position as a trusted and respected name in the healthcare sector.
Procter & Gamble Health Ltd is primarily present in India.
Procter & Gamble Health Ltd represents strong values and a corporate philosophy centered around improving lives through innovative healthcare solutions. With a commitment to delivering quality health and wellness products, the company strives to enhance the well-being of individuals and families worldwide. Procter & Gamble Health Ltd emphasizes integrity, excellence, and collaboration in all aspects of its operations. By continuously investing in research and development, the company aims to provide trusted and effective healthcare solutions to meet the diverse needs of consumers. With its customer-centric approach and dedication to advancing healthcare, Procter & Gamble Health Ltd is a leading player in the industry.
Analyytikot asettavat tällä hetkellä Procter & Gamble Health-osakkeelle keskimääräisen tavoitehinnan 5 339,70 INR (mediaani: 5 339,70 INR), mikä merkitsee +3,5 % viimeisimpään hintaan verrattuna. Konsensus perustuu 7 analyytikkoarvioon.
7 analyytikkoa arvioi tällä hetkellä Procter & Gamble Health-osaketta: 6 suosittaa ostoa, 1 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat Procter & Gamble Health-yhtiöltä 13,52 Mrd. INR liikevaihtoa ja 189,89 INR osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Procter & Gamble Health-osake noteerataan hintaan 47,60 EUR (5 158,00 INR).
Procter & Gamble Health-osake (PGHL.NS) on listattuna 2 pörssissä, muun muassa: NSE (Indien) (PGHL.NS).
Procter & Gamble Health Ltd is a leading company in the health and personal care industry, offering a wide range of innovative products and solutions. The company offers products in various categories, including baby care, skincare, oral care, and women’s health. Its baby care products include diapers, wet wipes, baby soap, and baby oil. The skincare products include a wide range of items such as moisturizers, body lotions, and cleansers. The oral care products include toothpaste, mouthwash, and dental floss. The women’s health products include feminine hygiene products such as sanitary pads, tampons, and panty liners. Procter & Gamble Health Ltd strives to develop its products based on innovation, quality, and safety. The company invests in research and development to ensure that its products meet the highest quality standards. It also engages in clinical studies to verify the effectiveness and safety of its products. In addition to selling retail products, Procter & Gamble Health Ltd also operates an extensive business in the medical professionals’ sector. The company conducts educational programs for doctors and medical practitioners to improve their understanding of the products and their application. It also collaborates with leading medical institutions to advance research and innovation in the healthcare industry. Procter & Gamble Health Ltd has a strong global presence and operates in more than 180 countries. The company has a strong market position in the major markets of Europe, Americas, Asia, and the Middle East. It also works with leading distribution partners in all regions to ensure that its products are available worldwide. Overall, Procter & Gamble Health Ltd has a successful business model based on the development and provision of innovative health and personal care products. The company is committed to quality and safety and engages in research and development as well as medical education programs to strengthen its position in the industry. With a large global presence and a diverse product portfolio, Procter & Gamble Health Ltd is well-positioned to continue its successful growth and meet the needs of its customers worldwide.
odotettu liikevaihto Procter & Gamble Health on 13,52 Mrd. INR. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Procter & Gamble Health on 3,15 Mrd. INR. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Procter & Gamble Health:n hinta-voitto-suhde (P/E) on tällä hetkellä 27,16. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Procter & Gamble Health-osakkeen arvostusta.
Procter & Gamble Health:n hinta-myynti-suhde (P/S) on tällä hetkellä 6,33. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Procter & Gamble Health-osakkeen arvostuskennuslukuna.
Procter & Gamble Health:n Eulpool-laatuscore on 5/10.
Procter & Gamble Health:n ISIN on INE199A01012. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Procter & Gamble Health:n ticker on PGHL.NS. Tämä pörssinoteeraus käytetään Procter & Gamble Health-osakkeiden kauppaan pörssissä.
Procter & Gamble Health osake
Procter & Gamble Health vertaisryhmä
Procter & Gamble Health Ticker
Procter & Gamble Health FIGI
Kaikki tunnusluvut ja syvällinen analyysi Procter & Gamble Health:sta
Meidän osakeanalyysimme Procter & Gamble Health-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Procter & Gamble Health:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: